Cardiac Amyloidosis Imaging: Do We Need Quantification?

This webinar provides an overview of the diagnosis of cardiac amyloidosis in nuclear cardiology . Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. In this context, the relevance of quantification to characterize disease and how to assess reliably the effects of therapy are presented.

• To gain a insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.
• To learn the possibilities of quantification of planar and SPECT studies in amyloidosis

• Nuclear physicians, cardiologists, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics and quantification